Disease expert ‘not worried’ that COVID-19 vaccine was rushed process
Experts say manufacturing and distribution will happen faster than usual because, as part of Operation Warp Speed, companies were in trial and preparing for production at the same time. That usually doesn't happen because the financial risk is too great.
•
Nov 19, 2020, 12:11 AM
•
Updated 1,346 days ago
Share:
More Stories
Hometown Heroes in the Hudson Valley
2ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
147ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
168ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
295ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
295ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds agoHometown Heroes in the Hudson Valley
2ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
147ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
168ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
295ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
295ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds agoAre health care officials sacrificing safety for speed when
it comes to a COVID-19 vaccine?
Pfizer announced on Wednesday that it will apply
"within days" to the FDA for emergency use approval. Pfizer's CEO
said the company wouldn't take that step until it's COVID-19 vaccine met three
key criteria.
- It had to be proven effective – meaning it can prevent COVID-19 in majority of patients.
- It had to be proven safe with data from thousands of patients.
- It could be manufactured consistently at highest quality standards.
Dr. Bettina Fries, the chief of infectious diseases at
Stony Brook Medicine, says she’s “not worried that this was rushed.”
“I am not concerned that the FDA will not apply the same
safety standards to this vaccine that they would apply to any vaccine,” says
Dr. Fries.
The FDA has said it would not grant emergency use approval
to any COVID-19 vaccine unless it had an efficacy rating of at least 50%.
Experts say manufacturing and distribution will happen
faster than usual because, as part of Operation Warp Speed, companies were in
trial and preparing for production at the same time. That usually doesn't
happen because the financial risk is too great.
The FDA will look at results from the clinical trial in
addition to two months of safety data and manufacturing records. The agency
will also convene an outside panel of experts to consider Pfizer's application.
That could take several weeks.
